Clinical trial
Time to Reduce Mortality in End-Stage Renal Disease (TiME) Trial
NCT02019225 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Time to Reduce Mortality in End-Stage Renal Disease (TiME) Trial
- Lead sponsor
- University of Pennsylvania
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 18, 2013
- Completion date
- April 30, 2017
- Enrollment
- 7,053 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease